Artelo Biosciences Research Development Over Time
| ARTL Stock | USD 1.29 0.04 3.01% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Artelo Biosciences Performance and Artelo Biosciences Correlation. Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Artelo Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Artelo Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Artelo Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Artelo Biosciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Research Development Analysis
Compare Artelo Biosciences and related stocks such as GT Biopharma, Protagenic Therapeutics, and Carisma Therapeutics Research Development Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GTBP | 400 K | 17 K | 1000 K | 1000 K | 1000 K | 1000 K | 975 K | 1.1 M | 9.1 M | 1.7 M | 485 K | 9.6 M | 8.8 M | 6.5 M | 5.8 M | 6.7 M | 7 M |
| PTIX | 456.3 K | 456.3 K | 337 | 456.3 K | 159.4 K | 464 | 417.9 K | 717.5 K | 881.2 K | 807.9 K | 699.8 K | 1.1 M | 1.6 M | 3.3 M | 3.8 M | 4.4 M | 4.6 M |
| CARM | 9.4 M | 9.4 M | 15.3 M | 13.8 M | 26.7 M | 26 M | 12.2 M | 12.2 M | 13.9 M | 24.4 M | 23.3 M | 25.2 M | 56.6 M | 74.1 M | 59.7 M | 68.6 M | 72.1 M |
| PBM | 137.2 K | 137.2 K | 137.2 K | 137.2 K | 137.2 K | 137.2 K | 137.2 K | 137.2 K | 137.2 K | 137.2 K | 137.2 K | 137.2 K | 1.6 M | 954.6 K | 342.2 K | 308 K | 608.6 K |
| REVB | 2.6 K | 2.6 K | 2.6 K | 2.6 K | 2.6 K | 2.6 K | 2.6 K | 2.6 K | 2.6 K | 2.6 K | 2.6 K | 6.9 M | 5.4 M | 4.1 M | 3.5 M | 4.1 M | 4.4 M |
| LIPO | 682.9 K | 682.9 K | 682.9 K | 682.9 K | 682.9 K | 682.9 K | 682.9 K | 682.9 K | 682.9 K | 682.9 K | 976 K | 1.5 M | 2.5 M | 3 M | 3.6 M | 4.2 M | 2.3 M |
| SPRC | 1.2 M | 2 M | 2.3 M | 1.3 M | 462.3 K | 238.5 K | 738.8 K | 2 M | 2.7 M | 1.6 M | 649 K | 2 M | 2.8 M | 1.6 M | 1.8 M | 1.6 M | 1.4 M |
| SLXN | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.7 M | 5.8 M | 6.7 M | 4.7 M |
| WINT | 1.2 M | 17.2 M | 21.6 M | 27.7 M | 26.7 M | 28.9 M | 31.7 M | 17.4 M | 10.6 M | 12.7 M | 15.4 M | 17.8 M | 11.1 M | 8.3 M | 16.3 M | 18.7 M | 18.7 M |
Artelo Biosciences and related stocks such as GT Biopharma, Protagenic Therapeutics, and Carisma Therapeutics Research Development description
My Equities
My Current Equities and Potential Positions
| Artelo Biosciences | ARTL |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 505 Lomas Santa |
| Exchange | NASDAQ Exchange |
USD 1.29
Check out Artelo Biosciences Performance and Artelo Biosciences Correlation. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Artelo Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.